- Home
- AMRX vs PRKS Comparison
AMRX vs PRKS Comparison
Compare AMRX & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- PRKS
- Stock Information
- Founded
- AMRX 2002
- PRKS 1959
- Country
- AMRX United States
- PRKS United States
- Employees
- AMRX N/A
- PRKS N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AMRX Health Care
- PRKS Health Care
- Exchange
- AMRX Nasdaq
- PRKS Nasdaq
- Market Cap
- AMRX 2.3B
- PRKS 2.4B
- IPO Year
- AMRX N/A
- PRKS 2013
- Fundamental
- Price
- AMRX $7.82
- PRKS $44.06
- Analyst Decision
- AMRX Strong Buy
- PRKS Buy
- Analyst Count
- AMRX 4
- PRKS 13
- Target Price
- AMRX $11.50
- PRKS $57.85
- AVG Volume (30 Days)
- AMRX 1.6M
- PRKS 631.9K
- Earning Date
- AMRX 08-08-2025
- PRKS 08-06-2025
- Dividend Yield
- AMRX N/A
- PRKS N/A
- EPS Growth
- AMRX N/A
- PRKS 3.53
- EPS
- AMRX N/A
- PRKS 3.85
- Revenue
- AMRX $2,830,186,000.00
- PRKS $1,714,827,000.00
- Revenue This Year
- AMRX $9.84
- PRKS $2.47
- Revenue Next Year
- AMRX $7.33
- PRKS $2.32
- P/E Ratio
- AMRX N/A
- PRKS $11.39
- Revenue Growth
- AMRX 13.42
- PRKS N/A
- 52 Week Low
- AMRX $6.29
- PRKS $37.68
- 52 Week High
- AMRX $9.48
- PRKS $60.83
- Technical
- Relative Strength Index (RSI)
- AMRX 54.91
- PRKS 50.47
- Support Level
- AMRX $7.72
- PRKS $40.64
- Resistance Level
- AMRX $8.11
- PRKS $43.80
- Average True Range (ATR)
- AMRX 0.26
- PRKS 1.14
- MACD
- AMRX 0.05
- PRKS 0.01
- Stochastic Oscillator
- AMRX 72.12
- PRKS 88.14
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.